| Accord Healthcare AG - Dasatinib Accord 50 mg, Filmtabletten | | 69965 | | 02 | | Dasatinib Accord 50 mg | | Filmtabletten | | L01EA02 | | Dasatinib | | 20.01.2025 | | |
| | Composition | | dasatinibum 50 mg ut dasatinibum monohydricum, lactosum monohydricum 65.654 mg, cellulosum microcristallinum, hydroxypropylcellulosum, carmellosum natricum conexum corresp. natrium max. 0.72 mg, magnesii stearas, Überzug: hypromellosum, E 171, triacetinum, pro compresso obducto. | | Packungsbestandteile | | Coated tablets | | | | Active Agent | Dose |
|---|
| Dasatinib | 50 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | Hydroxypropylcellulosum | | | | Hypromellosum | | Überzug | | Lactose Monohydrate | 65.654 mg | | | Magnesii Stearas | | | | Pro Compresso Obducto | | | | Triacetinum | | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | 60 | PR | PR | A | | No |
|
|
